Patents Assigned to NEXALIN TECHNOLOGY, INC.
  • Patent number: 12629519
    Abstract: A method for treating a patient for anxiety, depression, and insomnia. The method includes generating a stimulation conveyed to the patient for a treatment duration current via generating a carrier waveform being an alternating current having a duty cycle ratio and a current amplitude ratio being selected such that each respective integration of the current amplitude between successive time instances at which the carrier waveform alternates polarity is substantially equivalent. The method further includes generating a stimulation current from the carrier waveform via amplitude modulating the carrier waveform. The extremes of the stimulation current defining a stimulation current envelope defining first and second series of pulses. The first series of pulses occurring at a first frequency that does not substantially vary for the entire treatment duration, and the second series of pulses occurring at a second frequency that varies during the treatment duration.
    Type: Grant
    Filed: February 21, 2024
    Date of Patent: May 19, 2026
    Assignee: NEXALIN TECHNOLOGY, INC.
    Inventor: John Patrick Claude
  • Patent number: 12263336
    Abstract: Electrostimulation systems and methods are contemplated in which a high current level, charge balanced alternating current electrical signal is generated for delivery to the cortex region of a patient's brain for treating opioid use disorder and substance use disorder. By stimulating this region of the brain with a charged balanced stimulation current with a stimulation current envelope defining one or more series of pulses at particular frequencies and durations designed to evoke metabolic response in the neurons, significant improvements in efficacy and reductions in patient discomfort may be achieved relative to earlier methods of transcranial electrical stimulation. Further advantages, especially in promoting neural entrainment, may be realized as well via utilizing multiple series of pulses at different frequencies, and via the dynamic adjustment of the stimulation waveform via incorporation of feedback signals in order to maintain charge balance in real-time.
    Type: Grant
    Filed: July 14, 2021
    Date of Patent: April 1, 2025
    Assignee: NEXALIN TECHNOLOGY, INC.
    Inventor: John Patrick Claude
  • Patent number: 12011591
    Abstract: Transcranial electrostimulation systems and methods are contemplated in which a high current level, charge balanced alternating current electrical signal is generated for delivery to the occipital region of a patient's brain. By stimulating the brain with a charged balanced stimulation current with a stimulation current envelope defining one or more series of pulses at particular frequencies and durations designed to evoke metabolic response in the neurons, significant improvements in efficacy and reductions in patient discomfort may be achieved relative to earlier methods of transcranial electrical stimulation, especially those in which result in a resultant rectified direct current component being administered to the patient.
    Type: Grant
    Filed: June 27, 2023
    Date of Patent: June 18, 2024
    Assignee: NEXALIN TECHNOLOGY, INC.
    Inventor: John Patrick Claude
  • Patent number: 11944806
    Abstract: Electrostimulation systems and methods are contemplated in which a high current level, charge balanced alternating current electrical signal is generated for delivery to the frontal cortex region of a patient's brain. By stimulating this region of the brain with a charged balanced stimulation current with a stimulation current envelope defining one or more series of pulses at particular frequencies and durations designed to evoke metabolic response in the neurons, significant improvements in efficacy and reductions in patient discomfort may be achieved relative to earlier methods of transcranial electrical stimulation, especially those in which result in a resultant rectified direct current component being administered to the patient.
    Type: Grant
    Filed: June 3, 2021
    Date of Patent: April 2, 2024
    Assignee: NEXALIN TECHNOLOGY, INC.
    Inventor: John Patrick Claude
  • Patent number: 11872397
    Abstract: Transcranial electrostimulation systems and methods are contemplated in which a high current level, charge balanced alternating current electrical signal is generated for delivery to the occipital region of a patient's brain. By stimulating the brain with a charged balanced stimulation current with a stimulation current envelope defining one or more series of pulses at particular frequencies and durations designed to evoke metabolic response in the neurons, significant improvements in efficacy and reductions in patient discomfort may be achieved relative to earlier methods of transcranial electrical stimulation, especially those in which result in a resultant rectified direct current component being administered to the patient.
    Type: Grant
    Filed: December 9, 2020
    Date of Patent: January 16, 2024
    Assignee: NEXALIN TECHNOLOGY, INC.
    Inventor: John Patrick Claude
  • Patent number: D1073092
    Type: Grant
    Filed: November 17, 2023
    Date of Patent: April 29, 2025
    Assignee: NEXALIN TECHNOLOGY, INC.
    Inventors: Mark H. White, John Patrick Claude
  • Patent number: D1092758
    Type: Grant
    Filed: March 19, 2025
    Date of Patent: September 9, 2025
    Assignee: NEXALIN TECHNOLOGY, INC.
    Inventors: Mark H. White, John Patrick Claude